223 related articles for article (PubMed ID: 37745071)
1. Recent insights about pyrrolidine core skeletons in pharmacology.
Poyraz S; Döndaş HA; Döndaş NY; Sansano JM
Front Pharmacol; 2023; 14():1239658. PubMed ID: 37745071
[TBL] [Abstract][Full Text] [Related]
2. Structure activity relationship (SAR) and anticancer activity of pyrrolidine derivatives: Recent developments and future prospects (A review).
Bhat AA; Singh I; Tandon N; Tandon R
Eur J Med Chem; 2023 Jan; 246():114954. PubMed ID: 36481599
[TBL] [Abstract][Full Text] [Related]
3. Pyrrolidine in Drug Discovery: A Versatile Scaffold for Novel Biologically Active Compounds.
Li Petri G; Raimondi MV; Spanò V; Holl R; Barraja P; Montalbano A
Top Curr Chem (Cham); 2021 Aug; 379(5):34. PubMed ID: 34373963
[TBL] [Abstract][Full Text] [Related]
4. Natural Product-Derived Chiral Pyrrolidine-2,5-diones, Their Molecular Structures and Conversion to Pharmacologically Important Skeletons.
Habel D; Nair DS; Kallingathodi Z; Mohan C; Pillai SM; Nair RR; Thomas G; Haleema S; Gopinath C; Abdul RV; Fritz M; Puente AR; Johnson JL; Polavarapu PL; Ibnusaud I
J Nat Prod; 2020 Jul; 83(7):2178-2190. PubMed ID: 32584573
[TBL] [Abstract][Full Text] [Related]
5. Therapeutic Journey and Recent Advances in the Synthesis of Coumarin Derivatives.
Sinha S; Singh K; Ved A; Hasan SM; Mujeeb S
Mini Rev Med Chem; 2022; 22(9):1314-1330. PubMed ID: 34784861
[TBL] [Abstract][Full Text] [Related]
6. Therapeutic potential of pyrrole and pyrrolidine analogs: an update.
Jeelan Basha N; Basavarajaiah SM; Shyamsunder K
Mol Divers; 2022 Oct; 26(5):2915-2937. PubMed ID: 35079946
[TBL] [Abstract][Full Text] [Related]
7. Synthesis of Pyrrolidine- and γ-Lactam-Containing Natural Products and Related Compounds from Pyrrole Scaffolds.
Olivier WJ; Smith JA; Bissember AC
Chem Rec; 2022 Mar; 22(3):e202100277. PubMed ID: 34862727
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and anticonvulsant activity of new N-mannich bases derived from benzhydryl- and isopropyl-pyrrolidine-2,5-dione.
Rybka S; Obniska J; Rapacz A; Filipek B; Żmudzki P
J Enzyme Inhib Med Chem; 2016 Dec; 31(6):1038-47. PubMed ID: 26406340
[TBL] [Abstract][Full Text] [Related]
9. Tailoring the substitution pattern of Pyrrolidine-2,5-dione for discovery of new structural template for dual COX/LOX inhibition.
Sadiq A; Mahnashi MH; Alyami BA; Alqahtani YS; Alqarni AO; Rashid U
Bioorg Chem; 2021 Jul; 112():104969. PubMed ID: 34023639
[TBL] [Abstract][Full Text] [Related]
10. Pyrrolidine derivatives as antibacterial agents, current status and future prospects: a patent review.
Bhat AA; Tandon N; Tandon R
Pharm Pat Anal; 2022 Nov; 11(6):187-198. PubMed ID: 36366974
[TBL] [Abstract][Full Text] [Related]
11. New Strategies in the Efficient Total Syntheses of Polycyclic Natural Products.
Liu W; Hong B; Wang J; Lei X
Acc Chem Res; 2020 Nov; 53(11):2569-2586. PubMed ID: 33136373
[TBL] [Abstract][Full Text] [Related]
12. Synthesis, Anticonvulsant and Antinociceptive Activity of New Hybrid Compounds: Derivatives of 3-(3-Methylthiophen-2-yl)-pyrrolidine-2,5-dione.
Góra M; Czopek A; Rapacz A; Dziubina A; Głuch-Lutwin M; Mordyl B; Obniska J
Int J Mol Sci; 2020 Aug; 21(16):. PubMed ID: 32796594
[TBL] [Abstract][Full Text] [Related]
13. Synthesis, physicochemical, and anticonvulsant properties of new N-Mannich bases derived from pyrrolidine-2,5-dione and its 3-methyl analog.
Rybka S; Obniska J; Rapacz A; Filipek B; Kamiński K
Arch Pharm (Weinheim); 2014 Oct; 347(10):768-76. PubMed ID: 25139813
[TBL] [Abstract][Full Text] [Related]
14. Anticonvulsant properties of N-(4-methylpiperazin-1-yl)- and N-[3-(4-methyl-piperazin-1-yl)propyl] derivatives of 3-aryl- and 3-spirocycloalkyl-pyrrolidine-2,5-dione.
Obniska J; Jurczyk S; Zejc A; Kamiński K; Tatarczyńska E; Stachowicz K
Pharmacol Rep; 2005; 57(2):170-5. PubMed ID: 15886415
[TBL] [Abstract][Full Text] [Related]
15. A review on antioxidant potential of bioactive heterocycle benzofuran: Natural and synthetic derivatives.
Chand K; Rajeshwari ; Hiremathad A; Singh M; Santos MA; Keri RS
Pharmacol Rep; 2017 Apr; 69(2):281-295. PubMed ID: 28171830
[TBL] [Abstract][Full Text] [Related]
16. Japan-China Joint Medical Workshop on Drug Discoveries and Therapeutics 2008: The need of Asian pharmaceutical researchers' cooperation.
Nakata M; Tang W
Drug Discov Ther; 2008 Oct; 2(5):262-3. PubMed ID: 22504718
[TBL] [Abstract][Full Text] [Related]
17. Synthesis of Three-Dimensionally Fascinating Diterpenoid Alkaloids and Related Diterpenes.
Liu XY; Wang FP; Qin Y
Acc Chem Res; 2021 Jan; 54(1):22-34. PubMed ID: 33351595
[TBL] [Abstract][Full Text] [Related]
18. Novel Hybrid Anticonvulsants Derived from Pyrrolidine-2,5-dione Scaffold with Broad Spectrum of Activity in the Preclinical Studies.
Kaminski K
Curr Top Med Chem; 2017; 17(8):858-874. PubMed ID: 27697054
[TBL] [Abstract][Full Text] [Related]
19. Advances in matrix metalloproteinase inhibitors based on pyrrolidine scaffold.
Cheng XC; Wang Q; Fang H; Xu WF
Curr Med Chem; 2008; 15(4):374-85. PubMed ID: 18288992
[TBL] [Abstract][Full Text] [Related]
20. Thiazolidin-2,4-Dione Scaffold: An Insight into Recent Advances as Antimicrobial, Antioxidant, and Hypoglycemic Agents.
Kumar H; Aggarwal N; Marwaha MG; Deep A; Chopra H; Matin MM; Roy A; Emran TB; Mohanta YK; Ahmed R; Mohanta TK; Saravanan M; Marwaha RK; Al-Harrasi A
Molecules; 2022 Oct; 27(19):. PubMed ID: 36235304
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
